| Depression and anxiety in pregnancy. | |
| | |
MedLine Citation:
|
PMID: 21041870 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
The risk of depression in women is greatest during the child-bearing years. Considering that about 50% of pregnancies are unplanned, women may become pregnant while on antidepressants, may have their depression or anxiety relapse during pregnancy or postpartum, or may be unwell and untreated before and during pregnancy and the postpartum period. The impact of the symptoms of depression and anxiety can cause risk to the mother and also have a negative effect on child development. This presentation is intended to assist in understanding the impact of untreated maternal depression and anxiety on fetus, neonate, child and mother; to review the effects of fetal exposure to psychotropic medications (antidepressants); and to summarize general management of perinatal mood/anxiety disorders. |
| | |
Authors:
|
Alicja Fishell |
Publication Detail:
|
Type: Journal Article Date: 2010-10-26 |
Journal Detail:
|
Title: Journal of population therapeutics and clinical pharmacology = Journal de la thérapeutique des populations et de la pharamcologie clinique Volume: 17 ISSN: 1710-6222 ISO Abbreviation: J Popul Ther Clin Pharmacol Publication Date: 2010 |
Date Detail:
|
Created Date: 2010-11-02 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101530023 Medline TA: J Popul Ther Clin Pharmacol Country: Canada |
Other Details:
|
Languages: eng Pagination: e363-9 Citation Subset: IM |
Affiliation:
|
Reproductive Life Stages Program, Women's College Hospital, Toronto, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pandemic influenza H1N1 2009--the Canadian experience.
Next Document: Herbal medicines and pregnancy.